Actualizado 26/06/2012 16:38
- Comunicado -

Janssen Submits European Marketing Authorisation Application for Canagliflozin in Type 2 Diabetes (y 2)

CONTACT: Media contacts: Europe Middle-East & Africa: Brigitte Byl, Phone:+32(0)14-60-7172; Investor contacts: Stan Panasewicz, Phone:+1-(732)-524-2524; Louise Mehrotra, Phone: +1-(732)-524-6491

Contenido patrocinado